According to the Kaplan–Meier survival analysis, ccRCC patients with high FoxM1 expression had obviously lower overall survival rates than did those with low FoxM1 expression (Figure 2B, Log-rank value =27.484, P < 0.001). This evidence concerns the gene FOXM1 and nonpapillary renal cell carcinoma.